World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00324584
Date of registration: 10/05/2006
Prospective Registration: No
Primary sponsor: University Hospital, Grenoble
Public title: Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study
Scientific title: Surveillance Des données De l’Autosurveillance glycémique Via Internet Et Le réseau téléphonique GSM Chez Le diabétique De Type 1 Sous Traitement Insulinique Par Pompe Externe : Etude Prospective randomisée PumpNet.
Date of first enrolment: April 2003
Target sample size: 40
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00324584
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 3
Countries of recruitment
France
Contacts
Name:     Pierre Y Benhamou, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Universty Hospital, Grenoble, France
Name:     Helene Hanaire, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital, Toulouse, France
Name:     Jean L Bosson, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  CIC-INSERM
Name:     Serge Halimi, MD
Address: 
Telephone:
Email:
Affiliation:  University Hospital, Grenoble, France
Key inclusion & exclusion criteria

Inclusion Criteria:

- Type 1 diabetes mellitus

- Age = 18

- HbA1c between 7.5 and 10%

- Treated with continuous subcutaneous insulin infusion for a minimum of 3 months

Exclusion Criteria:

- Unstabilized diabetic microangiopathy

- Ongoing pregnancy or planned pregnancy

- Unwilling to perform a minimum of 4 capillary blood tests per day

- Unable to use the GlucoNet device



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Type 1 Diabetes Mellitus
Intervention(s)
Device: Telemonitoring of glucose values using GlucoNet device
Primary Outcome(s)
Glycated hemoglobin HbA1c
monthly mean capillary blood glucose value
blood glucose variability index (MAGE Index and LBGI index)
frequency of hypoglycemic episodes (<70 mg/dl)
quality of life score (DQOL score)
Secondary Outcome(s)
Secondary ID(s)
DCIC 03 01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history